{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:18:40Z","timestamp":1787239120564,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T00:00:00Z","timestamp":1507680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/https:\/\/doi.org\/10.13039\/501100002428","name":"Austrian Research Fund\/FWF","doi-asserted-by":"publisher","award":["F3506"],"award-info":[{"award-number":["F3506"]}],"id":[{"id":"10.13039\/https:\/\/doi.org\/10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/https:\/\/doi.org\/10.13039\/501100002428","name":"Austrian Research Fund\/FWF","doi-asserted-by":"publisher","award":["W1232"],"award-info":[{"award-number":["W1232"]}],"id":[{"id":"10.13039\/https:\/\/doi.org\/10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/https:\/\/doi.org\/10.13039\/501100002428","name":"Austrian Research Fund\/FWF","doi-asserted-by":"publisher","award":["DA12970"],"award-info":[{"award-number":["DA12970"]}],"id":[{"id":"10.13039\/https:\/\/doi.org\/10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/https:\/\/doi.org\/10.13039\/501100001822","name":"Austrian Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/https:\/\/doi.org\/10.13039\/501100001822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/https:\/\/doi.org\/10.13039\/100000026","name":"Intramural Research Program of the National Institute on Drug Abuse, National Institutes of Health, USA","doi-asserted-by":"publisher","award":["DA00523"],"award-info":[{"award-number":["DA00523"]}],"id":[{"id":"10.13039\/https:\/\/doi.org\/10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.neuropharm.2017.10.006","type":"journal-article","created":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T22:15:34Z","timestamp":1507760134000},"page":"149-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"PA","title":["Fluorinated phenmetrazine \u201clegal highs\u201d act as substrates for high-affinity monoamine transporters of the SLC6 family"],"prefix":"10.1016","volume":"134","author":[{"given":"Felix P.","family":"Mayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine V.","family":"Burchardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Partilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierce V.","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Sandtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Blough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon D.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1339-7444","authenticated-orcid":false,"given":"Harald H.","family":"Sitte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.10.006_bib1","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/15563650.2016.1211288","article-title":"Adverse events related to the new psychoactive substance 3-fluorophenmetrazine - results from the Swedish STRIDA project","volume":"54","author":"Backberg","year":"2016","journal-title":"Clin. Toxicol. (Phila)"},{"key":"10.1016\/j.neuropharm.2017.10.006_bib2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2012.10.026","article-title":"Role of phenmetrazine as an active metabolite of phendimetrazine: evidence from studies of drug discrimination and pharmacokinetics in rhesus monkeys","volume":"130","author":"Banks","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib3","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/npp.2011.304","article-title":"The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue","volume":"37","author":"Baumann","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.10.006_bib4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1124\/jpet.110.176271","article-title":"In\u00a0vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the rat","volume":"337","author":"Baumann","year":"2011","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib5","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/npp.2012.204","article-title":"Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products","volume":"38","author":"Baumann","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.10.006_bib6","doi-asserted-by":"crossref","first-page":"15150","DOI":"10.1523\/JNEUROSCI.3223-14.2014","article-title":"Baths salts, spice, and related designer drugs: the science behind the headlines","volume":"34","author":"Baumann","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib7","unstructured":"Blough, B. E. R., NC, US), Rothman, Richard (Ellicott City, MD, US), Landavazo, Antonio (Raleigh, NC, US), Page, Kevin M. (Willow Spring, NC, US), Decker, Ann Marie (Durham, NC, US). 2013. Phenylmorpholines and analogues thereof . United States patent application 20130203752."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib8","unstructured":"Blough, B. E. T. F. R., Raleigh, North Carolina, 27607, US), Rothman, Richard (12719 Folly Quarter Road, Ellicott City, Maryland, 21042, US), Landavazo, Antonio (2313 Falls River Avenue, Raleigh, North Carolina, 27614, US), Page, Kevin M. (264 Michael Place, Willow Spring, North Carolina, 27592, US), Decker, Ann Marie (1300 Laurel Springs Drive, Durham, North Carolina, 27713, US). 2011. Phenylmorpholines and analogues thereof. WO\/2011\/146850."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00511403","article-title":"The role of co-transported sodium in the effect of indirectly acting sympathomimetic amines","volume":"332","author":"Bonisch","year":"1986","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/rcm.7134","article-title":"Analytical characterization of bioactive N-benzyl-substituted phenethylamines and 5-methoxytryptamines","volume":"29","author":"Brandt","year":"2015","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib11","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/dta.1686","article-title":"The new drug phenomenon","volume":"6","author":"Brandt","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejphar.2012.11.008","article-title":"Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogs","volume":"699","author":"Cozzi","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.toxlet.2015.11.013","article-title":"Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class","volume":"241","author":"Dinger","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib14","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/dta.1420","article-title":"AMT (3-(2-aminopropyl)indole) and 5-IT (5-(2-aminopropyl)indole): an analytical challenge and implications for forensic analysis","volume":"5","author":"Elliott","year":"2013","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib15","first-page":"79","article-title":"The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation","volume":"96","author":"Gray","year":"1962","journal-title":"J.\u00a0Anat."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00426841","article-title":"Comparison of behavior maintained by infusions of eight phenylethylamines in baboons","volume":"50","author":"Griffiths","year":"1976","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuropharm.2014.06.012","article-title":"Dopamine reuptake transporter (DAT) \u201cinverse agonism\u201d\u2013a novel hypothesis to explain the enigmatic pharmacology of cocaine","volume":"87","author":"Heal","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.10.006_bib18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.neuropharm.2005.08.008","article-title":"Serotonin-transporter mediated efflux: a pharmacological analysis of amphetamines and non-amphetamines","volume":"49","author":"Hilber","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.10.006_bib19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1124\/pr.108.000869","article-title":"SLC6 neurotransmitter transporters: structure, function, and regulation","volume":"63","author":"Kristensen","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib20","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0896-6273(94)90337-9","article-title":"Conducting states of a mammalian serotonin transporter","volume":"12","author":"Mager","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.10.006_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0014-2999(95)00478-5","article-title":"Psychostimulant-like effects of p-fluoroamphetamine in the rat","volume":"287","author":"Marona-Lewicka","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neuropharm.2015.09.004","article-title":"The new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue","volume":"101","author":"Marusich","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.10.006_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/7854_2016_63","article-title":"Application of a combined approach to identify new psychoactive street drugs and decipher their mechanisms at monoamine transporters","volume":"32","author":"Mayer","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/dta.1800","article-title":"Test purchase, synthesis, and characterization of 2-methoxydiphenidine (MXP) and differentiation from its meta- and para-substituted isomers","volume":"8","author":"Mclaughlin","year":"2016","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0304-4157(90)90008-Z","article-title":"Alteration of intracellular traffic by monensin; mechanism, specificity and relationship to toxicity","volume":"1031","author":"Mollenhauer","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2017.10.006_bib26","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2006.11.075","article-title":"The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain","volume":"559","author":"Nagai","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1124\/jpet.106.103622","article-title":"Interaction of amphetamines and related compounds at the vesicular monoamine transporter","volume":"319","author":"Partilla","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib28","doi-asserted-by":"crossref","first-page":"39316","DOI":"10.1074\/jbc.M112.371765","article-title":"Steric hindrance mutagenesis in the conserved extracellular vestibule impedes allosteric binding of antidepressants to the serotonin transporter","volume":"287","author":"Plenge","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.euroneuro.2014.12.012","article-title":"Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones","volume":"25","author":"Rickli","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12035-009-8053-4","article-title":"A\u00a0closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters","volume":"39","author":"Robertson","year":"2009","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-2999(02)01830-7","article-title":"Interaction of the anorectic medication, phendimetrazine, and its metabolites with monoamine transporters in rat brain","volume":"447","author":"Rothman","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/mol.115.101394","article-title":"Binding mode selection determines the action of ecstasy homologs at monoamine transporters","volume":"89","author":"Sandtner","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib33","doi-asserted-by":"crossref","first-page":"21505","DOI":"10.1074\/jbc.M112265200","article-title":"The role of zinc ions in reverse transport mediated by monoamine transporters","volume":"277","author":"Scholze","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib34","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0022-3565(24)39309-7","article-title":"Transporter-mediated release: a superfusion study on human embryonic kidney cells stably expressing the human serotonin transporter","volume":"293","author":"Scholze","year":"2000","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib35","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","article-title":"Pharmacological characterization of designer cathinones in\u00a0vitro","volume":"168","author":"Simmler","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib36","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neuropharm.2013.11.008","article-title":"Monoamine transporter and receptor interaction profiles of a new series of designer cathinones","volume":"79","author":"Simmler","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.10.006_bib37","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1471-4159.2009.06474.x","article-title":"The reverse operation of Na(+)\/Cl(-)-coupled neurotransmitter transporters\u2013why amphetamines take two to tango","volume":"112","author":"Sitte","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tips.2014.11.006","article-title":"Amphetamines, new psychoactive drugs and the monoamine transporter cycle","volume":"36","author":"Sitte","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib39","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1046\/j.1471-4159.2000.741317.x","article-title":"Characterization of carrier-mediated efflux in human embryonic kidney 293 cells stably expressing the rat serotonin transporter: a superfusion study","volume":"74","author":"Sitte","year":"2000","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib40","doi-asserted-by":"crossref","first-page":"31385","DOI":"10.1038\/srep31385","article-title":"Dissociable effects of the prodrug phendimetrazine and its metabolite phenmetrazine at dopamine transporters","volume":"6","author":"Solis","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib41","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","article-title":"Mechanisms of neurotransmitter release by amphetamines: a review","volume":"75","author":"Sulzer","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib42","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2014.0265","article-title":"New psychoactive substances: catalysing a shift in forensic science practice?","volume":"370","author":"Tettey","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrn1008","article-title":"Plasma membrane monoamine transporters: structure, regulation and function","volume":"4","author":"Torres","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib44","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1523\/JNEUROSCI.4901-04.2006","article-title":"Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool","volume":"26","author":"Venton","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib45","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/FTD.0000000000000240","article-title":"New psychoactive substances: chemistry, pharmacology, metabolism, and detectability of amphetamine derivatives with modified ring systems","volume":"38","author":"Welter-Luedeke","year":"2016","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib46","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1126\/science.1252884","article-title":"Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins","volume":"344","author":"Wilhelm","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2017.10.006_bib47","unstructured":"EMCDDA: http:\/\/www.emcdda.europa.eu\/activities\/action-on-new-drugs."},{"key":"10.1016\/j.neuropharm.2017.10.006_bib48","unstructured":"UNODC, EWA: https:\/\/www.unodc.org\/LSS\/Home\/NPS."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817304732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817304732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T05:53:10Z","timestamp":1750917190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817304732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":48,"alternative-id":["S0028390817304732"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.10.006","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluorinated phenmetrazine \u201clegal highs\u201d act as substrates for high-affinity monoamine transporters of the SLC6 family","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}